dc.creator | Lima, LL | |
dc.creator | Neto, JBC | |
dc.creator | Cayana, EG | |
dc.creator | Nociti, FH | |
dc.creator | Sallum, EA | |
dc.creator | Casati, MZ | |
dc.date | 2013 | |
dc.date | SEP | |
dc.date | 2014-07-30T14:30:43Z | |
dc.date | 2015-11-26T16:32:47Z | |
dc.date | 2014-07-30T14:30:43Z | |
dc.date | 2015-11-26T16:32:47Z | |
dc.date.accessioned | 2018-03-28T23:14:21Z | |
dc.date.available | 2018-03-28T23:14:21Z | |
dc.identifier | Clinical Oral Implants Research. Wiley-blackwell, v. 24, n. 9, n. 1055, n. 1059, 2013. | |
dc.identifier | 0905-7161 | |
dc.identifier | WOS:000322203500015 | |
dc.identifier | 10.1111/j.1600-0501.2012.02502.x | |
dc.identifier | http://www.repositorio.unicamp.br/jspui/handle/REPOSIP/59063 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/59063 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1270639 | |
dc.description | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description | Objectives: This study aimed to investigate the effect of Recombinant Human Parathyroid Hormone (PTH 1-34) on attenuating the influence of cigarette smoke on bone around titanium implants. Material and methods: Forty-eight female Wistar rats were used. At the begging of the study, 15 animals were randomly assigned to Group 1 (control) and received subcutaneous injections of saline solution, three-times/week, after implant placement. The other animals received intermittent cigarette smoke inhalation (CSI), 60 days prior and 60 days after implant placement (Al2O3-blasted titanium implants - 4.0 x 2.2 mm). After surgery, these animals were randomly assigned to: Group 2 - subcutaneous injections of saline solution, three-times/week (n = 16) and Group 3 - intermittent doses of PTH (1-34) (40 mu g/Kg), three-times/week (n = 17). Animals were sacrificed 60 days after surgery, and degree of bone-to-implant contact (BIC), bone area (BA) within the limits of the threads and proportion of mineralized tissue (PMT) adjacent to the implants (500 mu m wide zone) were separately obtained in cortical and cancellous bone. Results: Data analysis confirmed that CSI negatively affects bone around implants, as observed for BIC in cortical zone (Cohen's d (d) = -1.26) and for PMT in both zones (d = -6.09 and d = -4.46 for cortical and cancellous zones, respectively). In addition, in the presence of CSI, PTH (1-34) promoted the highest BIC in both regions and BA and PMT in cancellous bone (P < 0.05). The histometric parameter that was not influenced by both PTH and CSI (1-34) was BA in cortical bone (P > 0.05). Conclusion: In the presence of cigarette smoke, a factor related to poor bone healing and low bone density, PTH (1-34) increased bone volume around implants. | |
dc.description | 24 | |
dc.description | 9 | |
dc.description | 1055 | |
dc.description | 1059 | |
dc.description | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description | CNPq [471577/2007-3] | |
dc.language | en | |
dc.publisher | Wiley-blackwell | |
dc.publisher | Hoboken | |
dc.publisher | EUA | |
dc.relation | Clinical Oral Implants Research | |
dc.relation | Clin. Oral Implant. Res. | |
dc.rights | fechado | |
dc.rights | http://olabout.wiley.com/WileyCDA/Section/id-406071.html | |
dc.source | Web of Science | |
dc.subject | dental implants | |
dc.subject | osseointegration | |
dc.subject | PTH | |
dc.subject | smoking | |
dc.subject | Bone-mineral Density | |
dc.subject | Postmenopausal Women | |
dc.subject | Titanium Implants | |
dc.subject | Dental Implants | |
dc.subject | Vitamin-d | |
dc.subject | Rats | |
dc.subject | Osteoporosis | |
dc.subject | Cessation | |
dc.subject | Increases | |
dc.subject | Mass | |
dc.title | Parathyroid hormone (1-34) compensates the negative effect of smoking around implants | |
dc.type | Artículos de revistas | |